Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is for people who have had surgery and chemotherapy for triple negative or hormone receptor positive breast cancer.
Breast cancer that doesn’t have receptors for the hormones progesterone and oestrogen, or for the protein , is called triple negative breast cancer.
Breast cancer that has receptors for the hormones oestrogen and progesterone is called hormone receptor positive breast cancer.
Recruitment start: 9 September 2014
Recruitment end: 1 April 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Tutt
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 11 Apr 2019
CRUK internal database number: 12373
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
